Research Article | Open Access
Antonello Storniolo, Marisa Raciti, Alessandra Cucina, Mariano Bizzarri, Livia Di Renzo, "Quercetin Affects Hsp70/IRE1α Mediated Protection from Death Induced by Endoplasmic Reticulum Stress", Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 645157, 11 pages, 2015. https://doi.org/10.1155/2015/645157
Quercetin Affects Hsp70/IRE1α Mediated Protection from Death Induced by Endoplasmic Reticulum Stress
Relative to their normal counterparts, tumor cells generally exhibit a greater “stress phenotype” and express heat shock proteins (Hsp) that represent candidate targets for anticancer therapy. Here we investigated the role of Hsp70 in survival induced by endoplasmic reticulum (ER) stressors in human leukemia U937 cells. Quercetin, a major dietary flavonoid, or specific silencing affected the expression level of Hsp70 and did not allow the upregulation of inositol-requiring kinase 1α (IRE1α), the prototype ER stress sensor regulating the unfolded protein response (UPR), that protects the cells against the stress of misfolded proteins in the ER. The reduction of Hsp70 prevented the upregulation of immunoglobulin heavy-chain binding protein (BiP), but not of CCAAT/enhancer-binding protein-homologous protein (CHOP), and induced apoptosis. Also specific silencing of IRE1α or inhibition of its endoribonuclease activity by 4μ8c hampered the upregulation of BiP, but not of CHOP, and induced apoptosis. These results suggest that drugs affecting the Hsp70-IRE1α axis, like quercetin, or affecting directly IRE1α may represent an effective adjuvant antileukemia therapy.
Disturbances in ER calcium homeostasis or protein processing cause the accumulation of misfolded or unfolded proteins in the ER, a cellular condition referred to as “ER stress.” Adaptation to ER stress is mediated by the induction of the unfolded protein response (UPR), a regulated and complex signal transduction pathway transmitting information to the cytosol and nucleus to increase protein folding capacity of the ER [1–3]. However, cells undergo apoptosis when adaptation mechanisms are unable to alleviate the ER stress [4, 5]. Thus, the UPR serves to mitigate the stress or, alternatively, to eliminate stressed cells in order to protect the organism.
The hallmark of the UPR is the upregulation of ER chaperones and folding enzymes, which are required to bind the unfolded proteins and prevent their aggregation . Also a transient attenuation of protein synthesis participates to the UPR by limiting the load of proteins under conditions not well suited to their proper folding .
Three resident ER transmembrane sensors detect unfolded proteins in the ER to initiate three distinct UPR branches: inositol-requiring kinase-1α (IRE1α), activating transcription factor-6 (ATF6), and protein kinase RNA- (PKR-) like ER kinase (PERK) [3, 6–8]. All these sensors have luminal domains that bind BiP under nonstress conditions. Once the ER stress leads to accumulation of unfolded proteins, BiP is released from the UPR sensors and binds to the unfolded proteins. These events trigger the activation of the ER sensors [9, 10]. IRE1α is evolutionarily conserved from yeast to humans; it is a Ser/Thr protein kinase and endoribonuclease that, upon activation, initiates the splicing of the mRNA encoding X-box binding protein 1 (XBP-1), converting it into a highly active transcription factor, termed XBP-1s. This is a key regulator of ER folding capacity that upregulates important genes related to control of protein quality, ER translocation, glycosylation, and ER/Golgi biogenesis [11, 12]. XBP-1s regulates several UPR target genes including ER chaperones like BiP, transcription factors like CHOP, and other proteins . BiP plays an antiapoptotic and cytoprotective role in early embryogenesis, oncogenesis, neurodegenerative diseases, and atherosclerosis [13, 14], while CHOP has been linked to apoptosis [15, 16]. CHOP downregulates antiapoptotic proteins like Bcl2 and increases free oxygen species, causing mitochondrial membrane damage and cytochrome C release.
Heat shock proteins (Hsp), classified according to their approximate molecular size, comprise several members exhibiting different expression patterns or expressed in different cell compartments. The Hsp70 family has more than 8 members. It includes the major cytoplasmic forms called heat shock cognate (Hsc) 70, Hsp73, HspA8, Hsp70, the mitochondrial protein GRP75, and the endoplasmic reticulum-resident GRP78. Hsc70 is constitutively and ubiquitously expressed. Hsp70, also named Hsp72, is generally expressed at very low or undetectable levels in unstressed normal cells while it is highly expressed in many malignant tumors, consistent with the idea that it represents a prosurvival factor, playing an essential role as chaperone in protein folding [17–19]. Overexpressed Hsp72 can bind to IRE1α and enhance its RNase activity, promoting adaptation to ER stress and cell survival . A role of Hsp70 in tumorigenesis has been suggested, based on the fact that its overexpression in transgenic mice results in T-cell lymphoma . The high expression of Hsp70 in tumor cells increases the resistance to apoptosis and has been associated with poor prognosis of cancer patients [22–25]. An altered expression or function of Hsp70 has been implicated in other human diseases, associated with defects in protein conformation or folding, as disorders caused by mutant proteins or some neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease [26, 27]. Furthermore, it is known that Hsp70 downregulation results in apoptosis in cancer cells but not in untransformed cells, which makes this protein an attractive target for molecular cancer therapeutics and chemoprevention.
In the present studies we set out to investigate the role of Hsp70, constitutively expressed in human monoblastic leukemia U937 cells, in the regulation of the UPR induced by the ER stressors tunicamycin (TN) and thapsigargin (TG). TN inhibits N-linked glycosylation resulting in accumulation of misfolded proteins, whereas TG inhibits Ca++ uptake by the ER, both resulting in ER stress induction. Hsp70 was silenced or its expression was reduced by quercetin (Q) , a major dietary flavonoid, that is going to be evaluated in a cancer clinical trial, based on its antiproliferative and anti-tyrosine kinase activities .
The present studies demonstrate a functional link between Hsp70 and IRE1α: targeting Hsp70 with Q or specific silencing, while not modifying CHOP upregulation, did not allow the upregulation of IRE1α and BiP following ER stress and promoted cell death. These results indicate that quercetin, in combination with drugs causing endoplasmic reticulum stress, may represent an effective adjuvant antileukemia therapy.
2. Materials and Methods
Antibody anti-β-actin, BSA, FCS, HBSS, l-glutamine, penicillin-streptomycin, PBS, propidium iodide (PI), Q, RNAse, RPMI-1640, and tunicamycin were from Sigma-Aldrich (St. Louis, MO, USA). Antibodies anti-BiP, -caspase 3, -CHOP, -Hsp70, -Hsp90, -IRE1α, and -PARP were from Cell Signaling Technology (Beverly, MA, USA). Horseradish peroxidase- (HRP-) conjugated anti-rabbit- and anti-mouse-immunoglobulin antibodies, enhanced chemiluminescence (ECL) reagents, and Hyperfilm-ECL film were from Amersham (Arlington Heights, IL, USA). Lipofectamine RNAiMAX and OPTI-MEM medium, small interfering- (siRNA-) IRE1, and relative scrambled siRNA (Ambion) were from Life Technologies (Invitrogen, San Giuliano Milanese, Italy). 2-Phenylethynesulfonamide (PES) and 4μ8c were from Merck (INALCO, Milan, Italy). RC-DC protein assay, SDS-sample buffer, protein standard, SDS-PAGE reagents, and polyvinylidene difluoride (PVDF) membranes were from Bio-Rad Laboratories (Segrate, Italy). Antibody anti-tubulin, siRNA-Hsp70, and scrambled siRNA were purchased from Santa Cruz Biotechnology (Tebu-Bio, Magenta, Italy). Thapsigargin and z-VAD.fmk were from Calbiochem (San Diego, CA, USA). Other reagents were of the highest purity and purchased from Bio-Rad, Invitrogen, or Sigma.
2.2. Cell Viability and Growth
The human monoblastic leukemia cell line U937, derived from a patient with diffuse histiocytic lymphoma, was used. Cells were grown in complete medium (RPMI-1640 medium supplemented with 5% heat-inactivated FCS, 2 mM glutamine, 100 units/mL penicillin, and 100 μg/mL streptomycin) at 37°C, in fully humidified 95% room air/5% CO2. Cells were resuspended three times a week in fresh complete medium to 3 × 105/mL. Cell growth was evaluated by hemocytometry counts of cells excluding trypan blue (0.04% Trypan blue in PBS, w/v), and viability was assessed by calculating alive (trypan blue excluding) cells as percentage of all cells counted (trypan blue excluding and not excluding). Cells used in every experiment were ≥94% viable and taken from cultures in exponential growth. They were washed once and resuspended in complete medium, 1 × 106/mL, and transferred to multiwell plates. They were then treated with inhibitors or vehicles, incubated for 30 min, and subsequently exposed to test agents or, again, to vehicles. At the end of each experiment, the cells were gently mixed and aliquots were taken for cell counting, PI staining, and cell cycle analysis. The vehicles, even when used in combination, were ≤0.3% (v/v) and did not modify any investigated parameter in comparison with control cultures.
2.3. Flow Cytometry Analysis of Cell Death
Nuclear DNA fragmentation was quantified by flow cytometry of hypodiploic (subG1) DNA after cell fixation and PI staining [30, 31]. Briefly, cells were washed with PBS, pelleted and fixed in ice cold ethanol/water (70/30, v/v) for 1 h, pelleted again and washed twice with PBS, and finally resuspended in PBS containing RNAse (20 μg/mL) and PI (100 μg/mL). Events in the different cell cycle phases were gated manually using an EPICS XL cytofluorimeter (Beckman Coulter, Hialeah, Fl, USA). At least 10.000 events/sample were acquired. Collected data were analyzed using the Multicycle software for DNA content and cell cycle analysis (Phoenix Flow System, San Diego, CA, USA). The subG1 events representative of the apoptotic cells, and the events in the other cell cycle phases, are given as percentage of the total cell population.
Membrane permeability, indicative of cell death, was investigated by resuspending the cells in HBSS containing PI (200 μg/mL) at room temperature and analyzed by flow cytometry (EPICS-XL), measuring the fluorescence emission at >575 nm (FL3).
2.4. Western Blot Analysis
Whole cell lysates were prepared as previously described . Briefly, the cells were kept for 30 min on ice in lysis buffer (NaCl 150 mM, CaCl2 1 mM, MgCl2 1 mM, NaN3 0.1%, NaF 10 mM, Triton X-100 1% (v/v), orthovanadate 1 mM, aprotinin 2 μg/mL, leupeptin 2 μg/mL, iodoacetamide 10 mM, PMSF 2 mM, and pepstatin 20 μM). The appropriate volumes of 4x SDS-sample buffer (v/v) were then added. Cell lysates were briefly sonicated, warmed at 95°C for 5 min, and cleared by 14000 ×g centrifugation in a microfuge for 15 min at 4°C. Supernatants were collected and proteins were quantified by RC DC protein assay. Equal amounts of proteins were separated from the different samples by SDS-PAGE, and blotted onto PVDF membranes. Transfer efficiency was checked with Ponceau staining. The blots were blocked in tris-buffered saline (TBS) containing BSA 5% (w/v), probed with specific primary antibodies (anti-BiP, -CHOP, -Hsp70, -IRE1α, or -PARP), washed with PBS-Tween 20, and then incubated with the appropriate peroxidase-conjugated secondary antibody. Finally, in order to control protein loading, each membrane was probed to detect β-actin, tubulin, Hsp90, or caspase 3 and the appropriate peroxidase-conjugated secondary antibody. For each antibody were used the dilutions and incubation times suggested by the manufacturer. Immunodetection was performed using the ECL reagents and Hyperfilm-ECL film. Densitometry quantitation of the bands was performed using ImageJ software (National Institutes of Health, Bethesda, MD, USA) on a Mac OS X (Apple Computer International, Cupertino, CA, USA).
RNA knockdown was performed with pools of siRNA duplexes. Briefly, cells were washed and resuspended in OPTI-MEM medium, transfected with siRNA specific for human Hsp70 and scrambled siRNA (Santa-Cruz) or with siRNA specific for IRE1α and relative scrambled siRNA (Ambion), using Lipofectamine RNAiMAX according to the manufacturer’s guidelines and as we previously described . After 12 h of incubation, RPMI 1640 containing 20% fetal calf serum was added without removing the transfection medium. The cells were cultured for further 60 h. After centrifugation, the medium was replaced with fresh RPMI-1640, containing 10% fetal calf serum, and the cells cultured again in the presence or not of TN.
2.6. Statistical Analysis
Results are expressed as the mean ± standard deviation (SD) of repeated experiments, as indicated in the figure legends. Statistical differences between the data sets were evaluated using unpaired, two-tailed Student’s -test. Values of were considered statistically significant.
3.1. Survival of U937 Cells under Moderate ER Stress Conditions
TN and TG are ER stressors that induce U937 cell death in a dose-dependent manner and that activate a prosurvival pathway at low concentrations . In particular, TN (1 μM) caused a moderate increase of PI incorporating (PI+) cells (%) in comparison with untreated cultures (%) (Figure 1(a)), in addition to the appearance of % of sub-G1 events (Figure 1(b)). Similarly, TG (200 nM) caused a fall in cell viability (PI+ cells %) (Figure 1(a)) and induced the appearance of sub-G1 events (%) (Figure 1(b)). Sub-G1 events were studied by cytofluorimetry of cell cycle phases of cells fixed and stained with PI. The hypodiploid DNA events were easily discernible from the narrow peak of cells with diploid DNA content; they are considered to be indicative of apoptotic nuclei [30, 33]. Furthermore, analysis of events in the different cell cycle phases showed that TN (1 μM) and TG (200 nM) caused a decrease in S and G2M phases, while the percentage of G1 events were apparently unchanged (Figure 1(c)). Cell counts indicated that neither TN nor TG allowed cell growth (not shown). These results show that these ER stressors, at the indicated low concentrations, cause activation of a prosurvival pathway in U937 cells, arrested in G1 cell cycle phase. To investigate this prosurvival pathway, all the experiments were performed with TN 1 μM and TG 200 nM, and viability parameters were investigated after 24 h.
3.2. Quercetin Downregulates the Expression of Hsp70 in U937 Cells
Hsp70 is present at constitutively high levels in various human tumors, in contrast to its low expression in unstressed normal cells. It is an important chaperone that plays a key role in conformational maturation and stabilization of proteins involved in cell growth and survival. Also U937 tumor cells express constitutively rather high levels of Hsp70, not apparently modified by the ER stress induced by TN or TG (Figure 2(a)). Q is known to inhibit the synthesis of Hsp70 in some human cancer cell lines . This flavonoid, at high doses, is cytotoxic and can block proliferation of U937 cells (unpublished results). Thus, we used the concentration 10 μM to avoid its cytotoxic effects. We found that quercetin (30 min, cell pretreatment) reduced the expression of Hsp70 in U937 cells under basal conditions as well as upon TN or TG treatments (Figure 2(a)).
3.3. Hsp70 Protects ER Stressed Cells from Death
Q caused per se a moderate increase of U937 cell death, as determined by evaluation of PI+ cells (%) and sub-G1 events (%) (Figures 2(b) and 2(c)). However, when combined with TN or TG, it caused a conspicuous increase of PI+ cells and sub-G1 events (Figures 2(b) and 2(c)). Thus, Q turns the survival induced by the ER stressors into cell death. PES is a pharmacological inhibitor of Hsp70 [34, 35]. It (10 μM, 30 min cell pretreatment) was slightly cytotoxic for U937 cells (PI+ cells %; sub-G1 events %) and more cytotoxic when associated with TN or TG (Figures 2(b) and 2(c)). In order to rule out off-target effects of the pharmacological inhibitors, Hsp70 expression was silenced by specific siRNA. After transfection time (72 h), TN was added for the subsequent 24 h. In comparison with scr-siRNA, Hsp70 specific silencing brought about an effective reduction of Hsp70 (Figure 2(d)) and caused a strong increase of cell death in ER stressed cells (Figure 2(e)).
These results show that Hsp70 promotes survival of ER stressed cells.
3.4. Hsp70 and IRE1α Are Functionally Linked
Among the three major transmembrane sensors of ER stress (IRE1α, PERK, and ATF6), IRE1α is the prototype ER stress sensor, evolutionarily conserved from yeast to human. The cytoprotective output of IRE1α is present across all eukaryotes. We examined the expression level of this sensor in U937 cells treated with TN and found that it was upregulated after 6 h, even more after 12, 15, and 18 h, and it remained high after 24 h (Figure 3(a)). Similar results were obtained using TG, as ER stressor (not shown).
In order to investigate the link between Hsp70 and IRE1α, U937 cells were pretreated with Q or PES, as the former drug affects Hsp70 expression, while the latter inhibits it. Both pretreatments prevented the upregulation of IRE1α following ER stress (Figure 3(b)). To rule out any unspecific effect of the used inhibitors, IRE1α was analyzed by western blot in cells silenced for Hsp70. In comparison with scr-siRNA, Hsp70 silencing effectively decreased the expression of constitutive IRE1α and prevented the increased expression of this ER sensor caused by TN treatment (Figure 3(c)).
These experiments indicate a functional link between Hsp70 and IRE1α.
3.5. Hsp70 Regulates BiP Expression through IRE1α
A number of studies have shown that cell survival or death decisions during the UPR are, respectively, mediated via the antiapoptotic BiP or the proapoptotic CHOP. We therefore examined the expression of these proteins by western blot in ER stressed U937 cells. TN, as previously reported, resulted in upregulation of BiP and CHOP, which became evident after 6 h and increased after 12 and 24 h of treatment ; quercetin or specific silencing of Hsp70 did not influence the expression of CHOP, while they prevented substantially BiP upregulation (Figures 4(a) and 4(b)).
IRE1α is a Ser/Thr protein kinase and endoribonuclease that, upon activation, initiates the unconventional splicing of the X-box binding protein (XBP-1) mRNA. The product of this splicing is XBP-1s, a highly active transcription factor and one of the key regulators of ER folding capacity. 4μ8c is an inhibitor of IRE1α endoribonuclease activity . IRE1α inhibition with 4μ8c (10 μM, cell pretreatment 30 min) or its specific silencing prevented BiP, but not CHOP induction after 24 h of TN treatment (Figures 4(a) and 4(b)). When TG was used, similar results were observed (not shown). The inhibition of IRE1α by 4μ8c caused a slight increase of sub-G1 events, more evident after TN treatment (Figure 5(c)).
These results indicate that in U937 cells undergoing a moderate ER stress Hsp70 promotes BiP upregulation through IRE1α activity and that this ER sensor plays a prosurvival role.
3.6. Hsp70-IRE1α Axis Contrasts Apoptosis in ER Stressed Cells
TN and TG induce apoptosis in U937 cells as above and previously reported . Here we show that in these cells PARP-1 was cleaved, indicating caspase 3 activation (Figure 5(a)). Furthermore, conditions affecting Hsp70 expression, that is, the use of Q or specific silencing of Hsp70, increased PARP-1 cleavage, which appeared more conspicuous after cell treatment with TN (Figures 5(a) and 5(b)).
Detection by flow cytometry of sub-G1 events is considered to be indicative of apoptosis. An increase of sub-G1 events was observed after Hsp70 impairment with Q or after IRE1α inhibition with 4μ8c that was prevented by the use of z-VAD.fmk, a pan-caspase inhibitor (70 μM, pretreatment for 60 min) (Figure 5(c)).
These results indicate that either the impairment of Hsp70 expression or the inhibition of IRE1α endoribonuclease activity cause apoptosis of ER stressed U937 cells. Taken together, these findings suggest that Hsp70-IRE1α axis is a kind of hub around which are regulated survival and apoptosis mechanisms.
ER stress-activated gene transcription is mediated by three different but interconnected pathways: PERK-ATF-4, ATF6, and IRE1α-XBP-1s. The transducers of these pathways (PERK, ATF6, and IRE1α) sense the presence of unfolded proteins in the ER lumen and convey this information to the nucleus. IRE1α activation leads to XBP-1 alternative splicing and, among other proteins, to BiP upregulation involved in cell survival [9–13]. It is known that the knocking down of IRE1α enhances cell death under conditions of chronic ER stress and that prolonging of IRE1α signaling, independently of ER stress, can promote cell survival [37–39].
A functional crosstalk between Hsp70 and ER stress has been observed in a number of physiological and pathological conditions, such as a cellular model of Parkinson’s disease induced by 6-hydroxy dopamine (6-OHDA) or following proteasome inhibition [40, 41]. It has also been reported that the regulation of the UPR is associated with the formation of a stable complex between Hsp72 and the cytosolic domain of IRE1α and that Hsp72, although having no effect on the half-life of this ER sensor, enhances its RNase activity, suggesting a direct interaction . Overall, those results have shown that Hsp72 is a component of the UPRosome that, by binding IRE1α, enhances XBP-1 signaling and promotes adaptation to ER stress and cell survival.
In the present work we set out to explore the relationship between Hsp70 expressed by U937 leukemia cells and IRE1α, in order to test the hypothesis that constitutive Hsp70, enhancing the amplitude of IRE1α signaling, promotes cell survival under conditions of ER stress. To this end, we used doses of ER stressors causing a moderate ER stress allowing the survival of U937 cells and we inhibited Hsp70 expression by Q or specific siRNA.
The induction of the Hsp in higher organisms is regulated at the transcriptional and translational levels. The transcription of heat shock genes is regulated by the cis-acting heat shock element (HSE) in the promoter region and the trans-acting heat shock factor (HSF). Q action has been examined on the promoter region of the human Hsp70 gene, especially on the formation of the HSF-HSE complex after activation either in vivo by heat shock or in vitro by heat treatment, urea, or Nonidet P-40 . It was detected that Q inhibits the binding of HSF to the HSE both in vivo and in vitro. Thus, Q interaction with HSF leads to the inhibition of this transcription factor and of Hsp70 . Our studies have confirmed that this flavonoid affects Hsp70 expression also in human U937 cells under basal conditions and upon ER stress.
Q or specific silencing of Hsp70 prevented also the upregulation of IRE1α induced by ER stress, suggesting a functional link between Hsp70 and IRE1α, allowing the increased expression of the latter protein under conditions of ER stress that could be due to an increased translation of IRE1α or to a physical connection leading to an increased half-life of IRE1α. Although we did not explore the link of Hsp70 to the UPRosome, we were able to pinpoint that, under ER stress, the Hsp70-IRE1α axis permits the upregulation of BiP, while it is not affecting CHOP in U937 cells. In fact, the ER stressors induced both BiP and CHOP, while IRE1α downregulation prevented only the expression of BiP. However, the cells survived when both BiP and CHOP expression increased, while apoptosis was induced after inhibition of the Hsp70-IRE1α axis and BiP downregulation. The same effect on cell survival was obtained also after specific silencing of IRE1α or inhibition of its endoribonuclease activity with 4μ8c. Thus, Hsp70, by regulating IRE1α expression, plays a role in a survival pathway featuring BiP, since this protein is antiapoptotic and prevents ER stress-induced cell death [13, 14].
The accumulation of unfolded proteins following ER stress, in defect of IRE1α, is supposed to lead to the activation of the other two sensors . In this context the concomitant decrease of BiP may represent a crucial step, as this protein is an inhibitory chaperone of the three ER sensors. Thus, the possible activation of PERK, via ATF4, may cause the increased expression of the proapoptotic CHOP. As this scenario generally occurs in severe ER stress [42, 43], we hypothesize that the impairment of the Hsp70-IRE1α axis turns a mild ER stress into a severe ER stress, associated with increased expression of CHOP.
In conclusion, in this study we show that quercetin, a major dietary flavonoid, downregulates the expression of Hsp70 in monoblastic leukemia U937 cells. Quercetin or specific Hsp70 siRNA prevents the upregulation of IRE1α and BiP, during endoplasmic reticulum stress, induced by TN or TG. This condition of ER stress and dysregulation of IRE1α and BiP promotes cell death.
These results indicate that, during ER stress, Hsp70 and IRE1α represent candidate targets to kill leukemia cells and that quercetin may be employed at this purpose.
|ATF6:||Activating transcription factor 6|
|BiP:||Immunoglobulin heavy-chain binding protein|
|BSA:||Bovine serum albumin|
|CHOP:||CCAAT/enhancer-binding protein-homologous protein|
|FCS:||Fetal calf serum|
|GRP78:||78 kDa glucose-regulated protein|
|Hsp:||Heat shock protein|
|IRE1α:||Inositol-requiring kinase 1α|
|PBS:||Phosphate buffered saline|
|PERK:||Protein kinase RNA- (PKR-) like ER kinase|
|RC-DC protein assay:||Reducing agent and detergent compatible protein assay|
|SDS-PAGE:||Sodium-dodecyl-sulphate-polyacrylamide gel electrophoresis|
|siRNA:||Small interfering RNA|
|UPR:||Unfolded protein response|
|XBP-1:||X-box binding protein 1.|
Conflict of Interests
The authors declare that they have no conflict of interests relating to the present study.
Antonello Storniolo performed most of the experiments, participated in the study design, and analyzed results. Marisa Raciti performed several experiments. Alessandra Cucina and Mariano Bizzarri participated in the study design and analyzed the results. Livia Di Renzo designed the experiments, analyzed the results, coordinated the study group, and wrote the paper.
This work was supported by grants to Livia Di Renzo from Sapienza Ateneo 2011 (22.214.171.124.34.1) and Sapienza Ateneo 2012 (126.96.36.199.38.1).
- R. J. Kaufman, “Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls,” Genes & Development, vol. 13, pp. 1211–1233, 1999.
- H. P. Harding, M. Calfon, F. Urano, I. Novoa, and D. Ron, “Transcriptional and translational control in the mammalian unfolded protein response,” Annual Review of Cell and Developmental Biology, vol. 18, pp. 575–599, 2002.
- D. Ron and P. Walter, “Signal integration in the endoplasmic reticulum unfolded protein response,” Nature Reviews Molecular Cell Biology, vol. 8, no. 7, pp. 519–529, 2007.
- E. Szegezdi, S. E. Logue, A. M. Gorman, and A. Samali, “Mediators of endoplasmic reticulum stress-induced apoptosis,” EMBO Reports, vol. 7, no. 9, pp. 880–885, 2006.
- C. Xu, B. Bailly-Maitre, and J. C. Reed, “Endoplasmic reticulum stress: cell life and death decisions,” The Journal of Clinical Investigation, vol. 115, no. 10, pp. 2656–2664, 2005.
- H. P. Harding, I. Novoa, A. Bertolotti et al., “Translational regulation in the cellular response to biosynthetic load on the endoplasmic reticulum,” Cold Spring Harbor Symposia on Quantitative Biology, vol. 66, pp. 499–508, 2001.
- M. Schröder and R. J. Kaufman, “The mammalian unfolded protein response,” Annual Review of Biochemistry, vol. 74, pp. 739–789, 2005.
- F. Urano, A. Bertolotti, and D. Ron, “IRE1 and efferent signaling from the endoplasmic reticulum,” Journal of Cell Science, vol. 113, no. 21, pp. 3697–3702, 2000.
- A. Bertolotti, Y. Zhang, L. M. Hendershot, H. P. Harding, and D. Ron, “Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response,” Nature Cell Biology, vol. 2, no. 6, pp. 326–332, 2000.
- Y. Kimata, D. Oikawa, Y. Shimizu, Y. Ishiwata-Kimata, and K. Kohno, “A role for BiP as an adjustator for the endoplasmic reticulum stress-sensing IRE1,” Journal of Cell Biology, vol. 167, no. 3, pp. 445–456, 2004.
- K. Lee, W. Tirasophon, X. Shen et al., “IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response,” Genes & Development, vol. 16, no. 4, pp. 452–466, 2002.
- H. Yoshida, T. Matsui, A. Yamamoto, T. Okada, and K. Mori, “XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor,” Cell, vol. 107, no. 7, pp. 881–891, 2001.
- Y. Kozutsumi, M. Segal, K. Normington, M.-J. Gething, and J. Sambrook, “The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins,” Nature, vol. 332, no. 6163, pp. 462–464, 1988.
- D. Dong, M. Ni, J. Li et al., “Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development,” Cancer Research, vol. 68, no. 2, pp. 498–505, 2008.
- X.-Z. Wang, B. Lawson, J. W. Brewer et al., “Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153),” Molecular and Cellular Biology, vol. 16, no. 8, pp. 4273–4280, 1996.
- S. J. Marciniak, C. Y. Yun, S. Oyadomari et al., “CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum,” Genes & Development, vol. 18, no. 24, pp. 3066–3077, 2004.
- M. P. Mayer and B. Bukau, “Hsp70 chaperones: cellular functions and molecular mechanism,” Cellular and Molecular Life Sciences, vol. 62, no. 6, pp. 670–684, 2005.
- E. Schmitt, L. Maingret, P. E. Puig et al., “Heat shock protein 70 neutralization exerts potent antitumor effects in animal models of colon cancer and melanoma,” Cancer Research, vol. 66, no. 8, pp. 4191–4197, 2006.
- C. Garrido, E. Schmitt, C. Candé, N. Vahsen, A. Parcellier, and G. Kroemer, “HSP27 and HSP70: potentially oncogenic apoptosis inhibitors.,” Cell cycle, vol. 2, no. 6, pp. 579–584, 2003.
- S. Gupta, A. Deepti, S. Deegan, F. Lisbona, C. Hetz, and A. Samali, “HSP72 protects cells from ER stress-induced apoptosis via enhancement of IRE1α-XBP1 signaling through a physical interaction,” PLoS Biology, vol. 8, no. 7, Article ID e1000410, 2010.
- J.-S. Seo, Y.-M. Park, J.-I. Kim et al., “T cell lymphoma in transgenic mice expressing the human Hsp70 gene,” Biochemical and Biophysical Research Communications, vol. 218, no. 2, pp. 582–587, 1996.
- A. Samali and T. G. Cotter, “Heat shock proteins increase resistance to apoptosis,” Experimental Cell Research, vol. 223, no. 1, pp. 163–170, 1996.
- A. Saleh, S. M. Srinivasula, L. Balkir, P. D. Robbins, and E. S. Alnemri, “Negative regulation of the Apaf-1 apoptosome by Hsp70,” Nature Cell Biology, vol. 2, no. 8, pp. 476–483, 2000.
- C. Bivik, I. Rosdahl, and K. Öllinger, “Hsp70 protects against UVB induced apoptosis by preventing release of cathepsins and cytochrome c in human melanocytes,” Carcinogenesis, vol. 28, no. 3, pp. 537–544, 2007.
- L. Ravagnan, S. Gurbuxani, S. A. Susin et al., “Heat-shock protein 70 antagonizes apoptosis-inducing factor,” Nature Cell Biology, vol. 3, no. 9, pp. 839–843, 2001.
- P. J. Muchowski and J. L. Wacker, “Modulation of neurodegeneration by molecular chaperones,” Nature Reviews Neuroscience, vol. 6, no. 1, pp. 11–22, 2005.
- R. I. Morimoto, “Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging,” Genes & Development, vol. 22, no. 11, pp. 1427–1438, 2008.
- N. Hosokawa, K. Hirayoshi, H. Kudo et al., “Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids,” Molecular and Cellular Biology, vol. 12, no. 8, pp. 3490–3498, 1992.
- D. R. Ferry, A. Smith, J. Malkhandi et al., “Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition,” Clinical Cancer Research, vol. 2, no. 4, pp. 659–668, 1996.
- I. Nicoletti, G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi, “A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry,” Journal of Immunological Methods, vol. 139, no. 2, pp. 271–279, 1991.
- G. Matusali, G. Arena, A. De Leo, L. Di Renzo, and E. Mattia, “Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds,” Molecular Cancer, vol. 8, article 18, 2009.
- G. Marfè, E. Morgante, C. Di Stefano et al., “Sorbitol-induced apoptosis of human leukemia is mediated by caspase activation and cytochrome c release,” Archives of Toxicology, vol. 82, no. 6, pp. 371–377, 2008.
- M. Raciti, L. V. Lotti, S. Valia, F. M. Pulcinelli, and L. Di Renzo, “JNK2 is activated during ER stress and promotes cell survival,” Cell Death & Disease, vol. 3, article e429, 2012.
- J. I.-J. Leu, J. Pimkina, A. Frank, M. E. Murphy, and D. L. George, “A small molecule inhibitor of inducible heat shock protein 70,” Molecular Cell, vol. 36, no. 1, pp. 15–27, 2009.
- M. Granato, V. Lacconi, M. Peddis et al., “HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma,” Cell Death & Disease, vol. 4, no. 7, article e730, 2013.
- B. C. Cross, P. J. Bond, P. G. Sadowski et al., “The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 15, pp. E869–E878, 2012.
- F. Lisbona, D. Rojas-Rivera, P. Thielen et al., “BAX inhibitor-1 is a negative regulator of the ER stress sensor IRE1α,” Molecular Cell, vol. 33, no. 6, pp. 679–691, 2009.
- D. Han, A. G. Lerner, L. V. Walle et al., “IRE1α kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates,” Cell, vol. 138, no. 3, pp. 562–575, 2009.
- J. H. Lin, H. Li, D. Yasumura et al., “IRE1 signaling affects cell fate during the unfolded protein response,” Science, vol. 318, no. 5852, pp. 944–949, 2007.
- E. J. Ryu, H. P. Harding, J. M. Angelastro, O. V. Vitolo, D. Ron, and L. A. Greene, “Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease,” Journal of Neuroscience, vol. 22, no. 24, pp. 10690–10698, 2002.
- A. Szokalska, M. Makowski, D. Nowis et al., “Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response,” Cancer Research, vol. 69, no. 10, pp. 4235–4243, 2009.
- C. Hetz, “The unfolded protein response: controlling cell fate decisions under ER stress and beyond,” Nature Reviews Molecular Cell Biology, vol. 13, no. 2, pp. 89–102, 2012.
- D. T. Rutkowski, S. M. Arnold, C. N. Miller et al., “Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins,” PLoS Biology, vol. 4, no. 11, article e374, 2006.
Copyright © 2015 Antonello Storniolo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.